Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b2021cafa8df7b0dec20ae2c7682f639 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-605 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-605 |
filingDate |
2018-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44c7f0546fdf89e7b97aa55f640abb85 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e48aa771817b3bb0d19ae8bc7b7ca4ef http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af1e05783f623924cf71735a50d6028b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0fed16e2ee8adfccc0fbeb7d4b2bac68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b2e114a311d8f68786f49c014f274509 |
publicationDate |
2020-01-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
AU-2018276434-A1 |
titleOfInvention |
Long-acting GIP peptide analogues |
abstract |
Disclosed are glucose-dependent insulinotropic peptide (GIP)-derived peptide analogues GIP5-30 and GIP3-30 which are antagonists of the GIP receptor and comprises at least one fatty acid molecule to increase half-life while maintaining antagonistic properties. |
priorityDate |
2017-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |